GABRIEL VASERSTEIN: Open Payments
NPI 1013940105 · PLANTATION, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$836 in 27 payments from 8 companies in 2025. Trend: 2023 $66 · 2024 $606 · 2025 $836
Food & beverage: $636Education: $199
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $369 |
| Janssen Biotech, Inc. | 3 | $152 |
| GENZYME CORPORATION | 4 | $129 |
| Organon LLC | 5 | $71 |
| LEO Pharma Inc. | 1 | $46 |
| Organogenesis Inc. | 1 | $26 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
Products named: DUPIXENT, TREMFYA, VIA MATRIX, BLU-U, COSENTYX, VTAMA.
Industry payments across FL — which companies pay providers there.
